CanSinoBIO to Showcase China's Vaccine Innovation at 2025 World Government Summit in Dubai
The 12th edition of the World Government Summit (WGS 2025) brings together influential leaders, heads of state, and tech visionaries from 140 countries to collaborate on global progress over the next decade. The summit focuses on addressing rapid changes, evaluating humanity's progress, identifying improvement opportunities, and empowering future generations through effective governance and sustainability.
CanSinoBIO's participation in the summit represents a significant milestone in its global expansion, highlighting its commitment to global public health. By engaging with global leaders, the Company aims to showcase its growing influence, strengthen its biopharma position, and drive innovation and collaboration for a positive global impact.
Driving Global Health Solutions
CanSinoBIO positions itself as a global vaccine provider rooted in China, dedicated to offering innovative, high-quality, and affordable vaccines worldwide. Over the past sixteen years, CanSinoBIO has established an industry system that meet international standards, and leveraged five advanced technology platforms to develop dozens of innovative vaccine products targeting over ten infectious diseases. 'CanSinoBIO is honored to stand as the exclusive representative of Chinese biotechnology companies at the conference,' said Dr. Yu Xuefeng. 'Our participation in this global platform underscores our dedication to advancing public health solutions and engaging with our partners worldwide to build a healthier and more sustainable future. Moving forward, we will persist in developing a globally competitive pipeline for novel vaccines, such as inhaled tuberculosis vaccine, PBPV and VLP-Polio vaccine.'
Enhance Global Partnerships for Improved Global Health
CanSinoBIO actively builds global partnerships to boost local vaccine production and reduce vaccine disparities. Since 2019, it has expanded its international presence by strengthening its commercial team, increasing production capacity, and partnering with countries in the Middle East, Southeast Asia, and Latin America. Additionally, Menhycia®, the Company's quadrivalent meningococcal conjugate vaccine, has been granted Halal Decree by the Assessment Institute for Foods, Drugs and Cosmetics of Majelis Ulama Indonesia, which is a good reference for the Muslim world. CanSinoBIO has also secured Halal Decree for multiple vaccine products, making vaccines more accessible and affordable for people in the MENA region and beyond. This initiative contributes positively to the global public health system. CanSinoBIO has developed five advanced technological platforms and established a rich portfolio of pipeline products that prevent more than ten diseases, including meningitis, pneumonia, pertussis, diphtheria, tetanus, COVID-19, tuberculosis, shingles, Ebola virus disease etc. Additionally, the Company has multiple globally innovative vaccine products in clinical trial stage, such as its protein-based pneumococcal vaccine (PBPV) and recombinant polio vaccine (VLP-Polio). The PBPV is not serotype-dependent and has broader coverage (at lease 98% coverage of pnemococcal strains), highlighting the potential public health value of this vaccine.. Furthermore, VLP-Polio, a non-infectious polio vaccine that does not rely on live viruses, has secured $19 million in project funding from the Bill & Melinda Gates Foundation and is endorsed by the World Health Organization as a preferred vaccine for the future eradication of polio.
Moving forward, CanSinoBIO looks forward to continuing its collaboration with global partners to address the challenges posed by infectious diseases, fulfilling its social and international responsibilities, and contributing to the advancement of global public health.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
24 minutes ago
- Business Wire
Live on Newsmax Today, August 13, 2025 – Venu Holding Corporation Founder, Chairman, and CEO J.W. Roth Appears for Live Interview at 2:40 PM EDT
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)-- Venu Holding Corporation ("VENU" or the 'Company') (NYSE American: VENU), a developer, owner, and operator of upscale live music venues and premium hospitality destinations, Founder, Chairman, and CEO J.W. Roth has been invited to join Newsmax for an anticipated live segment at 2:40 PM EDT during the network's American Agenda broadcast. Roth will share his expertise and insights on the booming entertainment industry and VENU's role on shaping its future. VENU Founder, Chairman, and CEO J.W. Roth will join Newsmax for an anticipated live segment at 2:40 PM EST during the network's American Agenda broadcast. Watch live on cable, streaming platforms, or at Share Watch live on cable, streaming platforms, or at Source: Venu Holding Corporation About Venu Holding Corporation Venu Holding Corporation ("VENU") (NYSE American: VENU), founded by Colorado Springs entrepreneur J.W. Roth, is a premier hospitality and live music venue developer dedicated to building luxury, experience-driven entertainment destinations. VENU's campuses in Colorado Springs, Colorado, and Gainesville, Georgia, each feature Bourbon Brothers Smokehouse and Tavern, The Hall at Bourbon Brothers, and unique to Colorado Springs, the over 9,000-seat Ford Amphitheater and Roth's Sea and Steak. Expanding with new Sunset Amphitheaters in Oklahoma and Texas, VENU's upcoming large-scale venues will host between 12,500 and 20,000 guests, continuing VENU's vision of redefining the live entertainment experience. Click here for company overview. VENU has been recognized nationally by The Wall Street Journal, The New York Times, Denver Post, Billboard, VenuesNow, and Variety for its innovative and disruptive approach to live entertainment. Through strategic partnerships with industry leaders such as AEG Presents and NFL Hall of Famer and Founder of EIGHT Elite Light Beer, Troy Aikman, VENU continues to shape the future of the entertainment landscape. For more information, visit VENU's website, Instagram, LinkedIn, or X. Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.
Yahoo
41 minutes ago
- Yahoo
UMAC Gears Up to Report Q2 Earnings: What's in the Offing?
Unusual Machines UMAC is scheduled to release second-quarter 2025 results on Aug. 14, after market close. The company delivered a negative earnings surprise of 75% for the first quarter of 2025. Unusual Machines, Inc. Price and EPS Surprise Unusual Machines, Inc. price-eps-surprise | Unusual Machines, Inc. Quote UMAC's Q2 Expectations The Zacks Consensus Estimate for revenues is set at $2.1 million, implying 50.4% growth from the year-ago quarter's actual. The U.S. commercial drone market is anticipated to grow, seeing a CAGR of 12.5% from 2024 to 2033. We expect this expanding market to boost demand for secure and high-octane unmanned aerial systems across different sectors in the United States, aiding UMAC's top line. The Drones of America Act, introduced in the Senate on June 25, aimed at banning Chinese components, is anticipated to have benefited UMAC in terms of contract growth. An increasing number of government agencies and infrastructure providers adhering to the National Defense Authorization Act and the Blue UAS Framework is likely to have favored domestic manufacturers, supporting UMAC's growth. The consensus estimate for loss is pegged at 7 cents per share, whereas it incurred a loss of 16 cents a year ago. What Our Model Says About UMAC Our proven model does not conclusively predict an earnings beat for Unusual Machines this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter. UMAC has an Earnings ESP of 0.00% and a Zacks Rank #3 at present. You can see the complete list of today's Zacks #1 Rank stocks here. Earnings Snapshot Gartner, Inc. IT reported second-quarter 2025 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate. IT's adjusted earnings per share of $3.53 beat the Zacks Consensus Estimate by 4.4% and increased 9.6% from the year-ago quarter. Revenues of $1.7 billion beat the consensus estimate by a slight margin and improved 5.7% year over year. IQVIA Holdings Analytics Inc. IQV posted impressive second-quarter 2025 results. IQV's adjusted earnings were $2.81 per share, beating the Zacks Consensus Estimate by 1.8% and rising 6.4% on a year-over-year basis. Total revenues of $4 billion surpassed the consensus estimate by 1.5% and grew 5.3% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Gartner, Inc. (IT) : Free Stock Analysis Report IQVIA Holdings Inc. (IQV) : Free Stock Analysis Report Unusual Machines, Inc. (UMAC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
42 minutes ago
- Yahoo
AI is already creating a billionaire boom: There are now 498 AI unicorns—and they're worth $2.7 trillion
AI is minting billion-dollar startups faster than the dot-com era, with 100 unicorns born in the last two years, including OpenAI, Anthropic, and Scale AI. They join a total of nearly 500 AI companies with valuations of $1 billion or more, according to CB Insights. And the gold rush is far from over. No longer do business leaders need to spend decades building the next big thing to join the ranks of Bill Gates, Mark Zuckerberg, and Jeff Bezos at the top of the billionaires club; they just need to build an AI company. There are now some 498 AI unicorns, or private AI companies, valued at $1 billion or more, with a combined value of $2.7 trillion, according to CB Insights. A complete 100 of them were founded since 2023. There are more than 1,300 AI startups with valuations of over $100 million. Take Mira Murati, the former CTO of OpenAI, for example. Her startup, Thinking Machines Lab, has just closed a $2 billion seed round at a $12 billion valuation. We've not seen a tech boom like this since the late 90s and early 2000s, which propelled many of the tech giants of today, from eBay to Google, into the mainstream. While the dot-com boom can't be directly compared because the 'unicorn' label didn't exist then and billion-dollar private valuations weren't tracked, AI is creating billionaires at a record pace—and could even ring in an era of trillionaires. The AI billionaire boom With a boom in company valuation also comes hefty paydays for its founders, investors, and C-suite. In March, Bloomberg reported that four of the largest private AI companies, including OpenAI, Anthropic, Safe Superintelligence, and Anysphere, have created at least 15 billionaires with a combined net worth of $38 billion. More than a dozen unicorns have been crowned since then. AI startups are receiving massive investments, resulting in high valuations and wealth for founders and early investors. According to data from Crunchbase, global venture funding in 2024 edged above 2023's totals, with AI showing the biggest leap in amounts year-to-year. For the founders of Anthropic, including CEO Dario Amodei, reports indicate the Claude chatbot maker is in talks to raise $5 billion at a valuation of $170 billion. Amodei's net worth is now over the billion-dollar mark. Also joining the billionaire club is Liang Wenfeng. The founder and CEO of Chinese AI company DeepSeek is likely worth over $1 billion based on the estimated value of the low-cost AI company. And as investments into AI continue to boom, so do the net worths of billionaires working in them. Nvidia's CFO Colette Kress and EVP Jay Puri have become billionaires, joining its CEO Jensen Huang after its market cap surpassed $4 trillion. Similarly, Palantir's first billion-dollar quarter is dramatically increasing the wealth of the company's cofounders and C-suite. Peter Thiel and Alex Karp have each seen their net worth jump by $17 billion collectively. This story was originally featured on Sign in to access your portfolio
